5-Fluorouracil resistance mechanisms in colorectal cancer: from classical pathways to promising processes
Many people, including myself, wonder, 'Do GLP-1 drugs change metabolism?' It's a common question
Dubois-Deruy E, Peugnet V, Turkieh A, Pinet F
Both albiglutide and dulaglutide received FDA approval for the treatment of T2DM in 2014, with dulaglutide having an additional indication since 2020 to reduce the risk of major adverse cardiovascular events (MACE) in adults with T2DM and established cardiovascular disease or multiple cardiovascular risk factors [ Table 2 ]
Tirzepatide Injection vs Tirzepatide ODT Tirzepatide works through both GLP-1 and GIP receptor pathways
These agents are generally integrated into broader care plans rather than used in isolation